Antihistamines offer no meaningful benefit for itchiness associated with eczema and may cause cognitive harms such as slowed thinking, according to a McMaster University analysis of 47 trials involving more than 6,200 participants. The findings, published by researchers examining longstanding uncertainties around atopic dermatitis, suggest that dermatologists should not routinely prescribe the medications for the inflammatory skin condition.
Why Dermatologists Traditionally Prescribed Antihistamines for Eczema
Clinicians originally adopted the treatment habit because antihistamines successfully manage other itchy conditions like hives and bug bites, according to Dr. Derek Chu, senior author of the research and chair in allergy for the Canadian Institutes of Health Research at McMaster University in Hamilton, Ontario. Researchers initially believed histamine triggered eczema-related itching because the chemical drives immune responses in other contexts. Doctors also relied on older, sedating formulas to help patients sleep through nighttime scratching episodes, notes Dr. Clinton Dunn, an allergist in Norfolk, Virginia, and vice chair of the American College of Allergy, Asthma, and Immunology’s Dermatology Committee.
Subsequent research revealed that histamines do not actually drive the itch associated with atopic dermatitis. Instead, Dr. Dunn explains that the sensation stems from cytokine signaling between body cells. This shift in understanding has pushed dermatology care toward targeted therapies that suppress inflammation directly rather than blocking histamine pathways.
Did You Know? Approximately 31.6 million people in the United States—about 10 percent of the population—live with some form of eczema, a condition that disrupts sleep, daily functioning, and mental health through intense itching.
Cognitive Side Effects of First- Versus Second-Generation Antihistamines
The McMaster University review separated medications into two distinct categories based on their impact on symptoms and cognition. Modern, second-generation options—including drugs sold under brand names like Claritin, Reactine, Aerius, Allegra, Rupall, and Blexten—produced only minor changes in eczema severity and itch that fell short of what patients or clinicians consider a noticeable improvement. Meanwhile, older first-generation formulas such as Benadryl, Chlor-Tripolon, and Polaramine produced no noticeable improvement for skin symptoms.
The older medications also increased cognitive impairment risks, triggering drowsiness, confusion, and reduced performance at work or school. Dr. Chu notes that some first-generation drugs link directly to long-term cognitive decline and dementia. Second-generation alternatives carried significantly lower cognitive risks, with bilastine, desloratadine, and fexofenadine emerging as the least sedating options in the analysis.
Future Treatment Guidelines and Targeted Eczema Therapies
Current medical guidelines remain inconsistent regarding whether clinicians should recommend antihistamines for atopic dermatitis. However, Dr. Chu suggests that upcoming updates from professional organizations like the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology will reflect the new trial data.
Specialists already lean toward treatments that target the root causes of skin inflammation. Newer therapeutic classes include JAK inhibitors, which block cytokine inflammatory effects, and biologic medications such as tralokinumab and lebrikizumab that inhibit interleukin-13, a primary inflammatory cytokine driving eczema symptoms. Dr. Saira Q. Zafar, an allergist and immunologist with Schweiger Dermatology & Allergy in Millburn, New Jersey, emphasizes that while antihistamines should not replace true anti-inflammatory care for eczema, they remain valuable for patients who also manage separate conditions like hay fever or hives.
Pro Tip: If your eczema remains itchy and uncontrolled despite taking over-the-counter allergy medications, consult an allergist or dermatologist about modern targeted therapies that address underlying skin inflammation.
Frequently Asked Questions
Do antihistamines help cure eczema flare-ups?
No. According to the McMaster University analysis, antihistamines do not prevent flare-ups, improve sleep, or reduce eczema symptoms enough for patients to notice a meaningful difference.
Which antihistamines carry the highest risk of cognitive side effects?
First-generation antihistamines—such as diphenhydramine, chlorpheniramine, and hydroxyzine—carry higher risks of drowsiness, confusion, slowed thinking, and long-term cognitive concerns compared to newer second-generation drugs.
Are antihistamines completely useless for eczema patients?
Not necessarily. While they fail to treat eczema inflammation, doctors note they remain effective if a patient suffers from co-existing conditions like hives, bug bites, or allergic rhinitis.
What treatments actually work for eczema-related itch?
Current care focuses on controlling skin inflammation through therapies like JAK inhibitors and biologic medications that target specific immune system cytokines.
Join the Discussion: Have you or a family member tried antihistamines for eczema management? Share your experiences or questions in the comments below, and subscribe to our newsletter for the latest updates on dermatology research.